Health and Medicine

zinc pill on spoon over white background
September 26, 2016

Study shows excess dietary zinc worsens C. diff infection

Too much dietary zinc increases susceptibility to infection by Clostridium difficile — “C. diff” — the most common cause of hospital-acquired infections.

By Leigh MacMillan
September 23, 2016

Blood exposures for traditional healers

Traditional healers in sub-Saharan have a high rate of exposure to blood, putting them at risk for HIV and hepatitis C.

By Paul Govern
September 22, 2016

H. pylori and anemia – new evidence

The bacterium Helicobacter pylori has been linked to anemia and may be contributing to the incidence and severity of anemia worldwide.

By Bill Snyder
interior of home medicine cabinet
September 15, 2016

Study explores anti-viral potential of existing drugs

Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market.

By Bill Snyder
Large vs small sphere
September 15, 2016

Larger transplant centers produce improved outcomes: study

How many heart transplant programs do we really need? That was a question posed by a group of investigators, including Vanderbilt University Medical Center’s Ashish Shah, M.D., in a novel study that used a computerized algorithm to highlight the value of high-volume transplant centers with corresponding improved outcomes.

By Jessica Pasley
(iStockphoto)
September 15, 2016

Researchers eye potential schizophrenia ‘switch’

Researchers at Vanderbilt University Medical Center have discovered a key mechanism that explains how compounds they’re developing can suppress schizophrenia-like symptoms without side effects in mice.

By Bill Snyder
September 15, 2016

Study reveals new clues to cystic fibrosis ‘gender gap’

A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.”
By Bill Snyder
September 14, 2016

Restore T cells to fight leukemia

Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients.
By Bill Snyder
September 13, 2016

Risk factors for delirium

High levels of blood markers for vascular endothelial dysfunction were associated with longer periods of confusion in ICU patients, Vanderbilt researchers have discovered.
By Leigh MacMillan
September 9, 2016

In search of new cancer targets

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.
By Leigh MacMillan
September 8, 2016

Investigators create ‘Trojan Horse’ to fight Ebola

A multi-center research team including scientists from the Vanderbilt Vaccine Center has come up with a clever “Trojan Horse” strategy for thwarting the highly lethal Ebola virus.
By Bill Snyder
September 8, 2016

Going after the ‘heart attack gremlin’

A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target.
By Sanjay Mishra
September 1, 2016

Lemonade Stand grant boosts Tansey’s pediatric tumor research

William Tansey, Ph.D., professor of Cell Development and Biology and Ingram Professor of Cancer Research, has been awarded a two-year, $250,000 grant from Alex’s Lemonade Stand Foundation (ALSF) to study malignant rhabdoid tumors (MRTs).
By Christina Echegaray
1 … 95 96 97 98 99 … 197